These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

487 related items for PubMed ID: 16288282

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Memory stem cells sustain disease.
    Yu XZ, Anasetti C.
    Nat Med; 2005 Dec; 11(12):1282-3. PubMed ID: 16333266
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL.
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.
    Atanackovic D, Cao Y, Luetkens T, Panse J, Faltz C, Arfsten J, Bartels K, Wolschke C, Eiermann T, Zander AR, Fehse B, Bokemeyer C, Kroger N.
    Haematologica; 2008 Mar; 93(3):423-30. PubMed ID: 18287134
    [Abstract] [Full Text] [Related]

  • 13. Are CD8+CD122+ cells regulatory T cells or memory T cells?
    Suzuki H, Shi Z, Okuno Y, Isobe K.
    Hum Immunol; 2008 Nov; 69(11):751-4. PubMed ID: 18817826
    [Abstract] [Full Text] [Related]

  • 14. Characterization of a CD44/CD122int memory CD8 T cell subset generated under sterile inflammatory conditions.
    Mbitikon-Kobo FM, Vocanson M, Michallet MC, Tomkowiak M, Cottalorda A, Angelov GS, Coupet CA, Djebali S, Marçais A, Dubois B, Bonnefoy-Bérard N, Nicolas JF, Arpin C, Marvel J.
    J Immunol; 2009 Mar 15; 182(6):3846-54. PubMed ID: 19265164
    [Abstract] [Full Text] [Related]

  • 15. Graft-versus-leukemia and graft-versus-host reactions after donor lymphocyte infusion are initiated by host-type antigen-presenting cells and regulated by regulatory T cells in early and long-term chimeras.
    Xia G, Truitt RL, Johnson BD.
    Biol Blood Marrow Transplant; 2006 Apr 15; 12(4):397-407. PubMed ID: 16545723
    [Abstract] [Full Text] [Related]

  • 16. Bone marrow-derived mesenchymal stem cells decrease acute graft-versus-host disease after allogeneic hematopoietic stem cells transplantation.
    Tian Y, Deng YB, Huang YJ, Wang Y.
    Immunol Invest; 2008 Apr 15; 37(1):29-42. PubMed ID: 18214798
    [Abstract] [Full Text] [Related]

  • 17. Prolonged interleukin-2Ralpha expression on virus-specific CD8+ T cells favors terminal-effector differentiation in vivo.
    Kalia V, Sarkar S, Subramaniam S, Haining WN, Smith KA, Ahmed R.
    Immunity; 2010 Jan 29; 32(1):91-103. PubMed ID: 20096608
    [Abstract] [Full Text] [Related]

  • 18. The rationale for the IL-2-independent generation of the self-renewing central memory CD8+ T cells.
    Fearon DT, Carr JM, Telaranta A, Carrasco MJ, Thaventhiran JE.
    Immunol Rev; 2006 Jun 29; 211():104-18. PubMed ID: 16824121
    [Abstract] [Full Text] [Related]

  • 19. Comparative analysis of naïve and memory CD4+ and CD8+ T-cell subsets in bone marrow and G-CSF-mobilized peripheral blood stem cell allografts: impact of donor characteristics.
    Yakoub-Agha I, Saule P, Depil S, Grutzmacher C, Boulanger F, Magro L, Jouet JP, Dessaint JP, Labalette M.
    Exp Hematol; 2007 Jun 29; 35(6):861-71. PubMed ID: 17533040
    [Abstract] [Full Text] [Related]

  • 20. Growth and differentiation advantages of CD4+ OX40+ T cells from allogeneic hematopoietic stem cell transplantation recipients.
    Shindo T, Ishikawa T, Fukunaga A, Hori T, Uchiyama T.
    Biol Blood Marrow Transplant; 2008 Mar 29; 14(3):268-81. PubMed ID: 18275893
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.